INS and obesity disorder: While these results clearly demonstrate a critical role of FFAR4 in the protective effects on obesity and CMDs, other studies showed that FFAR4 is not needed for the anti-inflammatory and insulin-sensitizing effects of n-3 PUFAs [87,88].